199 related articles for article (PubMed ID: 38254188)
1. Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma.
Huang G; Zhang X; Xu Y; Chen S; Cao Q; Liu W; Fu Y; Jia Q; Shen J; Yin J; Zhang J
J Transl Med; 2024 Jan; 22(1):88. PubMed ID: 38254188
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
[TBL] [Abstract][Full Text] [Related]
3. Single-cell and bulk RNA sequencing reveals Anoikis related genes to guide prognosis and immunotherapy in osteosarcoma.
Zhong C; Yang D; Zhong L; Xie W; Sun G; Jin D; Li Y
Sci Rep; 2023 Nov; 13(1):20203. PubMed ID: 37980450
[TBL] [Abstract][Full Text] [Related]
4. Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor.
Zhang J; Liu W; Zou C; Zhao Z; Lai Y; Shi Z; Xie X; Huang G; Wang Y; Zhang X; Fan Z; Su Q; Yin J; Shen J
Clin Cancer Res; 2020 Jun; 26(11):2681-2692. PubMed ID: 31937612
[TBL] [Abstract][Full Text] [Related]
5. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
7. Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma.
Zhang Z; Zhu Z; Fu J; Liu X; Mi Z; Tao H; Fan H
Int Immunopharmacol; 2023 Feb; 115():109684. PubMed ID: 36630752
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell-like Properties in Osteosarcoma.
Lu B; He Y; He J; Wang L; Liu Z; Yang J; Gao Z; Lu G; Zou C; Zhao W
Mol Cancer Res; 2020 Jan; 18(1):57-67. PubMed ID: 31615908
[TBL] [Abstract][Full Text] [Related]
9. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
[TBL] [Abstract][Full Text] [Related]
10. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma.
Chen J; Guo X; Zeng G; Liu J; Zhao B
Comput Math Methods Med; 2020; 2020():8081973. PubMed ID: 33082842
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel vasculogenic mimicry-associated gene signature for the prognostic assessment of osteosarcoma patients.
Yan L; Li R; Li D; Zhu Y; Lv Z; Wang B
Clin Transl Oncol; 2023 Dec; 25(12):3501-3518. PubMed ID: 37219824
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of Nomograms to Assess Risk Factors and Overall Survival Prediction for Lung Metastasis in Young Patients with Osteosarcoma: A SEER-Based Study.
Liu Z; Li G; Liu H; Zhu J; Wang D
Int J Clin Pract; 2022; 2022():8568724. PubMed ID: 36380749
[TBL] [Abstract][Full Text] [Related]
14. Machine learning and experimental validation to construct a metastasis-related gene signature and ceRNA network for predicting osteosarcoma prognosis.
Liao Y; Liu Q; Xiao C; Zhou J
J Orthop Surg Res; 2022 Dec; 17(1):516. PubMed ID: 36457129
[TBL] [Abstract][Full Text] [Related]
15. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts.
Yiqi Z; Ziyun L; Qin F; Xingli W; Liyu Y
Technol Cancer Res Treat; 2020; 19():1533033820980769. PubMed ID: 33308057
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of copper-metabolism-related genes about prognosis and immune microenvironment in osteosarcoma.
Lin Z; He Y; Wu Z; Yuan Y; Li X; Luo W
Sci Rep; 2023 Sep; 13(1):15059. PubMed ID: 37700003
[TBL] [Abstract][Full Text] [Related]
17. Clinical model of pulmonary metastasis in patients with osteosarcoma: A new multiple machine learning-based risk prediction.
Su Z; Huang F; Yin C; Yu Y; Yu C
J Orthop Surg (Hong Kong); 2023; 31(2):10225536231177102. PubMed ID: 37288764
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Potent Multi-miRNA Signature for Prediction of Prognosis of Osteosarcoma Patients.
Luo X; Tang J; Xuan H; Liu J; Li X
Med Sci Monit; 2020 Feb; 26():e919272. PubMed ID: 32098942
[TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of systematic prognostic nomograms in patients over 60 years of age with osteosarcoma: A multicenter external verification study.
Shao Z; Li J; Liu Z; Bi S
Cancer Med; 2023 Apr; 12(8):9589-9603. PubMed ID: 36992547
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
[Next] [New Search]